An assessment of the design and dissemination of phase I clinical trials: where can we improve?

被引：0

|

作者：

Copsey, Bethan ^{[1
]}

Odutayo, Ayodele ^{[2
]}

Cook, Jonathan ^{[2
]}

Dutton, Susan ^{[2
]}

Altman, Douglas ^{[2
]}

Hopewell, Sally ^{[2
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

来源：

TRIALS | 2017年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

P220

引用

收藏

页数：1

相关论文

共 50 条

[31] Design of HIV noninferiority trials: where are we going?
Flandre, Philippe
AIDS, 2013, 27 (04) : 653 - 657
[32] Approximate Bayesian computation design for phase I clinical trials
Jin, Huaqing
Du, Wenbin
Yin, Guosheng
STATISTICAL METHODS IN MEDICAL RESEARCH, 2022, 31 (12) : 2310 - 2322
[33] The role of translational research in the design of phase I clinical trials
Belka, C
RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S136 - S136
[34] What should be the ideal design of phase I clinical trials?
Lau, Derick
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S76 - S76
[35] GRADUATE TRAINING OF SCIENTIST PRACTITIONER-ORIENTED CLINICAL PSYCHOLOGISTS - WHERE WE CAN IMPROVE
DRABMAN, RS
PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 1985, 16 (05) : 623 - 633
[36] DESIGN AND ANALYSIS OF PHASE-I CLINICAL-TRIALS
STORER, BE
BIOMETRICS, 1989, 45 (03) : 925 - 937
[37] Where are we really with clinical trials of combination immunotherapy?
Postow, Michael
JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
[38] Where do we stand with Randomized Clinical Trials?
Tognoni, Gianni
ASSISTENZA INFERMIERISTICA E RICERCA, 2016, 35 (04) : 197 - 201
[39] Clinical Trials in Myositis: Where Do We Stand?
Mann, Herman
Vencovsky, Jiri
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (03) : 222 - 242
[40] Evidence and clinical trials in Endourology: where are we going
Donaldson, James Fergus
McClinton, Samuel
CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 120 - 124

← 1 2 3 4 5 →